Additionally, the CD4+/CD8+ ratio in the COPD + TB CMV + group is significantly lower than in the CMV-uninfected groups, with the difference being statistically significant, marked as * (P < .05) (Fig. 1B). The gene discussed is CD8A; the disease is chronic obstructive pulmonary disease.